Figure 1From: Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors Receiver operating characteristic curve for febrile neutropenia occurrence in a) any cycle and b) cycle 1 of chemotherapy. ROC, receiver operating characteristic. *bysecting line indicates a predictiove ability that is no better than chance (ROC = 0.5).Back to article page